Modeling to Optimize Terminal Stem Cell Differentiation

Embryonic stem cell (ESC), iPCs, and adult stem cells (ASCs) all are among the most promising potential treatments for heart failure, spinal cord injury, neurodegenerative diseases, and diabetes. However, considerable uncertainty in the production of ESC-derived terminally differentiated cell types...

Descripción completa

Detalles Bibliográficos
Autor principal: Gallicano, G. Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820305/
https://www.ncbi.nlm.nih.gov/pubmed/24278782
http://dx.doi.org/10.1155/2013/574354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820305/
https://www.ncbi.nlm.nih.gov/pubmed/24278782
http://dx.doi.org/10.1155/2013/574354

Ejemplares similares